Fraunhofer Center for Molecular Biotechnology (FhCMB) is a  division of Fraunhofer  USA, Inc., a not-for-profit, research organization, whose mission is  to  develop safe and  effective  vaccines and  therapeutics targeting  infectious  diseases and  autoimmune  disorders. Our 56,000  square foot research and development facility also  houses a  state of the  art, cGMP pilot  facility which  uses  our  unique, plant-based  technology  to produce proteins. Two  clinical  trials  are  currently  underway.